SCHEMBL28238554

SCHEMBL28238554

O=C(NCc1cc[c]cc1)c1nc2ccccc2s1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.80
CNR1 P21554 2/20 0.62
CNR2 P34972 1/20 0.62
MAOB P27338 5/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
ALDH1A1 P00352 3/20 0.60
HPGD P15428 2/20 0.60
HDAC3 O15379 1/20 0.60
HDAC1 Q13547 1/20 0.60
HDAC2 Q92769 1/20 0.60
TP53 P04637 1/20 0.59
ROCK2 O75116 1/20 0.55
RAB9A P51151 4/20 0.53
NPC1 O15118 3/20 0.53
PKM P14618 1/20 0.53
NFKB1 P19838 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
MAPT P10636 2/20 0.53
KDM4E B2RXH2 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5330099 0.89 L3MBTL1 (1.00) L3MBTL1CNR1CNR2MAOBSMN1; SMN2
SCHEMBL14345990 0.84 L3MBTL1 (0.80) L3MBTL1CNR1CNR2MAOBSMN1; SMN2
SCHEMBL18641957 0.82 L3MBTL1 (0.76) L3MBTL1CNR1CNR2MAOBSMN1; SMN2
SCHEMBL6998874 0.79 L3MBTL1 (0.71) L3MBTL1CNR1CNR2MAOBSMN1; SMN2
SCHEMBL14345980 0.78 L3MBTL1 (0.70) L3MBTL1CNR1CNR2MAOBSMN1; SMN2
SCHEMBL3261601 0.76 MAOB (0.78) L3MBTL1MAOBSMN1; SMN2ALDH1A1ROCK2
SCHEMBL210149 0.75 SMN1; SMN2 (0.67) L3MBTL1CNR1CNR2MAOBSMN1; SMN2
SCHEMBL19380255 0.75 L3MBTL1 (0.66) L3MBTL1CNR1CNR2MAOBSMN1; SMN2
SCHEMBL28863161 0.75 HDAC1 (0.60) HDAC3HDAC1HDAC2RAB9ANAMPT
SCHEMBL17903693 0.74 L3MBTL1 (0.70) L3MBTL1CNR1CNR2MAOBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114685516-A Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer 洛克索肿瘤学股份有限公司 2022-07-01 CN disclosed
CN-108431007-B Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer 洛克索肿瘤学股份有限公司 2022-06-07 CN disclosed
CN-108431007-A PYRAZOLOPYRIMIDINE DERIVATIVES AS BTK INHIBITORS FOR THE TREATMENT OF CANCER 洛克索肿瘤学股份有限公司 2018-08-21 CN disclosed